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Patients who are newly screened HIV positive by EIA are lost to follow-up due to compli-
cated HIV testing procedures. Because this is the first step in care, it affects the entire con-
tinuum of care. This is a particular concern in rural China.
Objective(s)
To assess the routine HIV testing completeness and treatment initiation rates at 18 county-
level general hospitals in rural Guangxi.
Methods
We reviewed original hospital HIV screening records. Investigators also engaged with hos-
pital leaders and key personnel involved in HIV prevention activities to characterize in detail
the routine care practices in place at each county.
Results
699 newly screened HIV-positive patients between January 1 and June 30, 2013 across the
18 hospitals were included in the study. The proportion of confirmatory testing across the 18
hospitals ranged from 14% to 87% (mean of 43%), and the proportion of newly diagnosed
individuals successfully initiated antiretroviral treatment across the hospitals ranged from 3%
to 67% (mean of 23%). The average interval within hospitals for individuals to receive the
Western Blot (WB) and CD4 test results from HIV positive screening (i.e. achieving testing
completion) ranged from 14–116 days (mean of 41.7 days) across the hospitals. The shortest
interval from receiving a positive EIA screening test result to receiving WB and CD4 testing
and counseling was 0 day and the longest was 260 days.
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Conclusion
The proportion of patients newly screened HIV positive that completed the necessary test-
ing procedures for HIV confirmation and received ART was very low. Interventions are
urgently needed to remove barriers so that HIV patients can have timely access to HIV/
AIDS treatment and care in rural China.
Introduction
Studies worldwide have confirmed the life-saving benefits of the early initiation of antiretrovi-
ral therapy (ART) for people living with HIV (PLHIV) [1–4]. Most HIV-infected patients are
able to achieve viral suppression once they are successfully engaged in ART [5]. Over the past
decade, China, along with many other countries, has been actively exploring ways to improve
access to HIV testing and treatment services for affected individuals and communities. How-
ever, in many settings, HIV patients are lost at each step of the continuum of HIV care [6–10].
Poor engagement in HIV care remains a major obstacle for the successful implementation of
the Treatment as Prevention (TasP) strategy in China. Data from 2009 showed that only about
half (53.3%) of HIV-positive individuals were tested for CD4 cell count within six months of
the diagnosis of HIV infection [11]. Despite the provision of nation-wide HIV testing services
and free ART programs, the proportion of ART-eligible HIV-positive patients who successfully
receive treatment remains low (63.4%) [3].
In 2011, Guangxi Zhuang Autonomous Region (Guangxi) reported the highest number of
AIDS-related deaths among all 31 provinces, autonomous regions and municipalities in China,
accounting for 22% of the national total[12]. An earlier study suggested that in Guangxi, 50.4%
of those who screenedHIV-positive in hospital settings received a confirmatoryWestern Blot
test, and 76.0% of those confirmed to be HIV-positive received their HIV test results. Of the
individuals who were notified of their HIV-positive status, 31.4% did not receive CD4 testing
[13]. Since CD4 cell count levels are used to determine ART eligibility (the criterion was CD4
350 cells/mm3 or an AIDS diagnosis, at the time when the study was conducted), it was esti-
mated that nearly 80% of newly identified, ART-eligible patients in Guangxi were not receiving
ART timely [12].
Locally established practices, including the lengthy and complicated HIV referral process,
were felt to be the primary drivers of low rates of confirmatory testing completion and ART
initiation in this rural setting. In brief, the current standard of care following an initial positive
HIV screening test calls for a subsequent repeat screening test, followed at a subsequent visit by
an HIV confirmatory test (theWestern Blot test), which is sent off-site and generally takes 10–
15 days to complete. The patient is then expected to return to the facility for results and post-
WB test counseling. At this visit, a blood sample is typically collected for baseline CD4 cell
count measurement, which takes an additional 10 to 15 days. Patients must return to the facil-
ity or be located to learn their CD4 cell count test result and receive counseling regarding ART
eligibility. This process inevitably delays ART initiation and results in a high proportion of EIA
screenedHIV positive patients being lost to follow up, thereby missing opportunities for
patient engagement in HIV care, and posing significant barriers to achieving effective treat-
ment outcomes for patients that ultimately translates into highmortality rates [14,15].
Although data are available on patients with a confirmed diagnosis of HIV infection, the
current surveillance system does not actively monitor the testing completeness status of newly
screenedHIV cases prior to ART initiation (that is, the percentage of people who receive an
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HIV diagnosis after obtaining a positive HIV screening result). This prevents researchers and
policy-makers from gaining an accurate understanding of how linkage to HIV treatment and
care from testing can be further improved to enhance the continuum of care.
In order to develop strategies to streamline the approach and improve patient engagement
in care in hospital based settings, a study was designed and implemented by the National Cen-
ter for AIDS Control and Prevention (NCAIDS), Chinese Center for Disease Control and Pre-
vention, to identify the limitations of the current routine testing practices along the HIV




The present study included:
1. A cross-sectional review of hospital records to assess the proportion of newly screenedHIV
cases that completed testing and ART initiation in each study hospital. For this purpose,
hospital records in 18 county general hospitals for the period from January 1, 2013 to June
30 2013 were reviewed to identify the number of newly screenedHIV positive cases, their
testing completeness and ART initiation status. Original hospital screening records were
crosschecked against the data collected and stored in the National Comprehensive Response
Information Management System (CRIMS).
2. A status quo mapping of HIV testing to ART initiation processes, and deviations from the
standard of care. Investigators observed and documented key characteristics of the routine
care practice adopted at each county, which included: the types of test kits used at each hos-
pital for HIV screening, number of HIV screening tests required for an individual to be con-
sidered as a screened positive, number of blood draws required to achieve testing
completion, number of hospital visits needed to achieve testing completion, frequency of
blood sample delivery for off-site confirmatory testing, and cost of baseline physical exami-
nations. Variations from standard of care were documented and summarized. A detailed
pathway flowchart fromHIV screening to treatment was developed for each of the counties,
documenting the patient referral process and key deviations from the national guidelines
for HIV testing and care services.
3. A survey of hospital organizational and staffing characteristics. Hospital characteristics such
as number of beds, annual number of inpatients/outpatients, number of clinicians for HIV
care were collected using a separate survey for the purpose of baseline stratification for the
CTN-0056Ot study.
Study Site
State-owned hospitals in China are classified by a 3-tiered system based on the hospital’s capac-
ity to provide medical care and medical education and to conduct research. Level 1 Hospitals
are generally community-based or township hospitals with fewer than 100 beds and are mainly
responsible for providing preventive care. Level 2 Hospitals have between 100 and 500 beds,
and are located in counties or districts. These hospitals offer a range of comprehensive health
services, and have the capacity to provide some medical education and conduct limited
research at the regional level. Level 3 Hospitals are city, provincial or national-level hospitals
that are typically responsible for the provision of specializedmedical services, usually with a
HIV Care Continuum in Rural China
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bed capacity exceeding 500. These hospitals offer a wider range of services, and have higher
capacity to provide medical education and conduct research. Within this 3-tiered-system, hos-
pitals are further rated by 3 grades (A, B and C) based on hospital size, level of medical technol-
ogy, service provision and quality of service, resulting in a total of 9 levels. There is also one
additional special category (AAA) for the highest-rankedmedical facilities, also known as the
Level 3 Triple A Hospitals [16].
Each county usually have one county general hospital, one county woman and child care
hospital, and one county hospital of traditional Chinesemedicine and many township hospi-
tals. Policies and practice of recommendingHIV screening test varies among hospitals. HIV
screening test is recommended for all patients who are hospitalized. For out-patients, HIV
screening test is recommended if a patient has infections, or the doctor believes it is needed.
Usually, some 3% to 10% of out-patients are recommended for HIV screening test. For preg-
nant women attending antenatal care at the woman and child care hospital, everyone is recom-
mended for HIV screening test.
In Guangxi, counties usually have one Level 2A general hospital, which is designated as the
only medical facility for delivering ART services. Level 2A general hospitals were selected for
this study because they are also the largest health care facilities at the county-level in China’s
hospital system, with the greatest number of inpatients and outpatients. Almost one-third of
the total number of HIV cases in China are identified and reported from these hospitals[12].
Selected study hospitals had to have reported at least 20 HIV-positive screening cases in the
6-month period from January 1, 2013 to June 30, 2013. It should be noted that it was impossi-
ble to determine the number of newly screened positive cases from the reported number of
HIV-positive screening cases, as the current HIV surveillance does not distinguish between
newly screened and previously screened positive cases. Geographical location was also taken
into account to ensure coverage of the entire Guangxi region. The study team travelled to
twenty-four hospitals that fulfilled the above requirements. Eighteen hospitals were selected for
final statistical analysis, excluding hospitals with missing values and those with fewer than 5
newly screenedHIV-positive cases.
Study Participants
Study participants included locally newly screenedHIV positive individuals who were at least
18 years old, seeking care in the selected hospitals between January 1 and June 30, 2013. Prison-
ers, detainees and pregnant women were excluded. This is because, in Guangxi, all prisoners or
detainees who test HIV positive are followed up by the local Centers for Disease Control and
Prevention as well as medical staff at the detention facilities under a separate system and do
not receive HIV care at the general hospital. Pregnant women receive HIV care services at sep-
arate specializedmaternity care hospitals.
Data Collection
A standardized data collection form was developed a priori to accurately capture all the
required information. All site investigators were trained prior to the investigation.
Investigators engaged with hospital leaders and key personnel involved in HIV prevention
activities, which usually included one ART Clinician, one Hospital Laboratory Staff, one Hos-
pital Case Report Officer and one to two members from the County CDCHIV Division.
Information collected in this study has been used as baseline data in the CTN-0056OtTest-
ing and Linkage to HIV Care Clustered Randomized Controlled Trial Study (NCT02084316),
co-funded by the U.S. National Institute on Drug Abuse (NIDA), and the China National
Health and Family Planning Commission (NHFPC). This ongoing prospective study assesses
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the effects of a structural intervention to reduce the interval from HIV screening to ART initia-
tion in rural China.
Statistical Analysis
Statistical analyses presented are purely descriptive, where data within hospitals are tabulated
and summarized across the 18 hospitals, using means, medians, 25th and 75th quartiles, and
ranges. The total number of newly screenedHIV-positive cases identified between January 1,
2013 and June 30, 2013, along with the numbers and proportions of newly screened cases that
successfully received both theWestern Blot and CD4 testing with counseling were tabulated
and stratified by time-points, at 30 days, 60 days, 90 days, and up to the point of final observa-
tion.We documented the interval (days) from the initial positive EIA screening to confirma-
tory HIV testing (theWestern Blot test, and the CD4measurement) and counseling. The ART
initiation success rates for ART-eligible patients (i.e.: CD4 count 350 cells/mm3) were tabu-
lated by Study County. More detailed information about completion of WB test, CD4 test and
initiation of ART in the 18 hospital are available in S1 Dataset.
Ethics
This study was a secondary data analysis using existing hospital records. All patients signed an
informed consent upon for takingHIV test saying that their data, after removing their personal
identifications, could be used in epidemiological studies such as this. Therefore, no additional
study-specific consent for this current study was sought. The surveywas structured so that all
personally identifiable information was excluded. The patient records was de-identified and
anonymized prior to analysis. The study was reviewed and approved by the Institutional
ReviewBoard of the National Center for AIDS/STDControl and Prevention, Chinese Center
for Disease Control and Prevention.
Results
The 2009 National Guidelines for HIV/AIDSDetection recommend that when a patient is
screenedHIV positive on the initial screening, two subsequent repeat screening tests should be
carried out at the same time (preferably using different testing methodologies or reagent
brands from the initial screening)[17]. Only 5 hospitals out of the 18 hospitals followed the
national guidelines in this respect. Three County CDCs conducted EIA tests regardless of
patients’ screening results. The Guidelines [18] also recommend that a new blood draw always
be carried out when a patient needs to be tested for HIV confirmation in order to reduce con-
tamination rates and mishandling of blood samples. However, ten County CDCs used the
same blood sample collected for EIA screening to carry out theWB confirmatory testing. Addi-
tionally, the Guidelines recommend that a patient should always return to the hospital to col-
lect his or her test result and receive counseling. However, in most of the counties visited, after
the initial EIA screening at the hospital, patients would have to make at least one and often two
trips to the county CDC to collect theirWB and CD4 cell count test results.
A total of 699 eligible patient records from 18 county hospitals were reviewed and included
in the study, with an average of 39 newly screenedHIV-positive patients per hospital. The low-
est hospital identified 15 newly screenedHIV-positive patients and the highest 73. Details on
the number of newly screenedHIV-positive cases and their testing completeness rates in 18
Level 2A county-level general hospitals across Guangxi from January 1 to June 30 in 2013 are
shown in Table 1. The proportion of newly screenedHIV positive individuals who successfully
achieved testing completion (i.e. HIV screening,Western Blot test, CD4 cell count test) within
30 days of their HIV-screen positive result averaged across the 18 hospitals was 25.5% (range
HIV Care Continuum in Rural China
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of 0 to 86.7%, median 15.3%). This average percent across the hospitals increases to 43% (13.6–
86.7%, median 41.8%) for patients achieving testing completion at any time after receiving a
positive screening result, and is 37% (2.3–86.7%,median 39.8%) within 60 days, and 41.8%
(13.6–86.7%,median 41.8%) within 90 days. The proportion of patients who were confirmed
to have HIV (positiveWestern Blot) among those that did have a Western Blot performedwas
96.9%.
We also calculated the average number of days within hospital from receipt of initial HIV
positive EIA screening result to receipt of confirmatory results (theWestern Blot test, and the
CD4 cell count test) and completion of counseling (Table 2). The average time from HIV posi-
tive screening to receipt of confirmatory results and counseling across the 18 hospitals was 41.7
days (14–116 days, median 38 days), with a total of 11 out of 18 (61%) hospitals reporting an
average interval longer than 30 days (range: 116 to 14 days). At the individual patient level, the
shortest interval was 0 day and the longest 260 days.
The proportions of newly diagnosedHIV cases that initiated ART for each of the hospitals
are presented in Table 3. The proportion of all HIV positive individuals that initiated treat-
ment during observation averaged across the 18 hospitals was 21.8% (2.5–66.7%,median
19.9%). The hospital-averaged proportion of newly diagnosedHIV positive individuals that
had initiated treatment within 90 days of the initial EIA screening regardless of their treatment
Table 1. The number of newly screened HIV positive cases and the testing completeness proportions in 18 county general hospitals in Guangxi














































up to the point
of observation
1 44 0 0 1 2.3 6 13.6 6 13.6
2 29 0 0 4 13.8 5 17.2 5 17.2
3 40 2 5 6 15 7 17.5 7 17.5
4 33 2 6.1 14 42.4 16 48.5 16 48.5
5 41 4 9.8 8 19.5 10 24.4 14 34.1
6 36 4 11.1 7 19.4 8 22.2 8 22.2
7 34 4 11.8 10 29.4 14 41.2 14 41.2
8 40 5 12.5 8 20 10 25 11 27.5
9 29 4 13.8 7 24.1 10 34.5 10 34.5
10 48 8 16.7 21 43.8 24 50 26 54.2
11 43 13 30.2 16 37.2 16 37.2 16 37.2
12 47 15 31.9 21 44.7 24 51.1 24 51.1
13 26 10 38.5 11 42.3 11 42.3 11 42.3
14 33 13 39.4 15 45.5 17 51.5 17 51.5
15 73 32 43.8 38 52.1 41 56.2 41 56.2
16 37 18 48.6 24 64.9 24 64.9 25 67.6
17 51 27 52.9 32 62.7 35 68.6 36 70.6
18 15 13 86.7 13 86.7 13 86.7 13 86.7




39 (33, 44) 7 (4, 13) 15.3 (10.1,
39.2)
12 (8, 20) 39.8 (34, 45.3) 14 (23, 33) 41.8 (33, 51.4) 14 (22; 32) 41.8 (31, 53.5)
doi:10.1371/journal.pone.0164346.t001
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eligibility status was 19.4% (2.5–66.7%,median 15.7%). The average proportion of ART-eligi-
ble (i.e.: CD4 count350 cells/mm3) individuals that initiated treatment within 90 days was
18.0% (2.5%-66.7%,median 15.1%).
HIV care cascades by testing completeness and ART initiation status are shown in Fig 1.
Among all identified patients newly screenedHIV-positive between January 1 and June 30,
2013, 55.2% of patients did not achieve testing completion. 78.5% of patients were lost between
the initial HIV screening test and ART initiation. Only 17.2% of treatment-eligible patients
successfully initiated ART treatment within 90 days after the initial HIV screening test.
Discussion
Previous limited studies conducted in Guangxi suggested that only some 50% of patients
screenedHIV-positive received confirmation testing. Our study suggests that the figure could
be even lower at the county level at 43%. Our results also confirm that only 22% of newly iden-
tifiedART-eligible patients in Guangxi are engaged in HIV treatment timely, an alarmingly
low treatment coverage rate compared to other low- and middle-income countries[19].
A major cause for the low testing completion and treatment initiation in rural Guangxi is
the complicated and lengthy diagnostic pathway, and the disjointed HIV services,which are
constrained by local structural and cultural factors. Currently, there are huge variations in the
quality of HIV care offered in different counties. County hospitals and CDCs often struggle to
follow national guidelines on standard of care for HIV services,mainly because of laboratory
capacity limitations and the complexity of the referral system between hospitals and CDCs.
Table 2. Average time interval from initial EIA HIV screening to confirmatory counselling in 18
county hospitals in Guangxi, China.
Hospital code Average time interval between EIA
positive and WB&CD4 counselling
(days)
Range of time interval between EIA
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When patients are screenedHIV positive, they often need to travel between the county hospital
and the county CDC several times in order to obtain confirmation of their HIV status, CD4
cell count testing, counseling, and subsequently initiate antiretroviral treatment.
Based on observations and conversations with the local staff members, we have learned that
some patients refused to undergo furtherHIV confirmatory testing as a result of being afraid
of related stigma and discrimination. This was consistent with our finding of a deep-rooted
stigma against HIV patients among the leaders and staff of local hospitals and CDCs providing
HIV care. Further, some officials and staff openly expressed their support for the use of puni-
tive measures, such as public shaming or revealingHIV positive individuals’ identity, as effec-
tive ways to curbHIV rates among lower-income sex workers. In addition, we learned that at
least some of the patients might have been turned away by hospital staff in an effort to avoid
patient follow-up and reporting to the national database. Counseling before HIV screening test
and personal contact information collection (address, contact number, etc.) after a positive
screening result were also important reasons for lost to follow-up.
There are two major underlying causes of this huge variability of standards of care across
hospitals. Firstly, most of the county-level hospitals follow a traditional stovepipe management
structure, where very little cross-organizational communication is promoted. Staff involved in
HIV testing and care (such as laboratory staff, Case Report Officers and ART clinicians) have
little interest in following up with the patients to ensure that adequate care is provided. There
are no assigned hospital staff to follow up on patients who do not return for their test results.
In addition, CDCs and hospitals have been operating under two separate and distinct
Table 3. The proportions initiating treatment in 18 county hospitals in Guangxi between January 1 and June 30, 2013.
Hospital
code
Proportion of treatment (CD4350) Proportion of treatment
(all)
Proportion of EIA positive that initiated ART up



















positive that initiated ART
up to the point of
observation
1 44 2 4.5 2 4.5 3 6.8
2 29 1 3.4 1 3.4 2 6.9
3 40 1 2.5 1 2.5 1 2.5
4 33 9 27.3 9 27.3 10 30.3
5 41 8 19.5 9 22.0 9 22.0
6 36 2 5.6 2 5.6 2 5.6
7 34 3 8.8 4 11.8 7 20.6
8 40 4 10.0 4 10.0 4 10.0
9 29 6 20.7 7 24.1 7 24.1
10 48 8 16.7 9 18.8 11 22.9
11 43 5 11.6 7 16.3 8 18.6
12 47 6 12.8 7 14.9 9 19.1
13 26 5 19.2 6 23.1 6 23.1
14 33 5 15.2 5 15.2 5 15.2
15 73 11 15.1 11 15.1 14 19.2
16 37 10 27.0 10 27.0 11 29.7
17 51 19 37.3 21 41.2 25 49.0
18 15 10 66.7 10 66.7 10 66.7
Average 39 6 18.0 7 19.4 8 21.8
Median (25th,
75th quartile)
39 (33, 44) 6 (3, 9) 15.1 (9.1, 20.4) 7 (4, 9) 15.7(10.4,
23.9)
8 (4, 10) 19.9 (11.3, 23.9)
doi:10.1371/journal.pone.0164346.t003
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jurisdictions, each with its own independent funding source from different government agen-
cies. The success of a patient receiving treatment through the current HIV testing process is
largely reliant on the relationship between the hospital and CDC at the county level. Many
patients are lost to follow up during this referral process, further highlighting the need to
streamline the current standard of care practice and co-locate HIV care serviceswithin one
setting.
We also found that there is limited hospital staff capacity, which conspires against active fol-
low-up of patients during the pre-ART phase. More than half of the hospitals (13) reported
that they are struggling to attract and retain health workers that are willing to work in HIV
care because of stigma, misconceptions of occupational exposure and financial disincentives.
Although public hospitals are by definition not-for-profit, all of them are under pressure to
generate revenue to cover operational and administrative costs, and turn earnings into addi-
tional infrastructurewhenever possible[20]. As most of the services related to HIV care are free
Fig 1. Cascade of Western Blot (WB) and CD4 Cell Count Testing Completion, Antiretroviral Therapy (ART) Initiation in 18 County Hospitals in
Guangxi between Jan-Jun 2013.
doi:10.1371/journal.pone.0164346.g001
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of charge generating no revenue, hospital administrators have no incentive to increase their
capacity in the provision of these services.At public hospitals, doctors and nurses are salaried
employees. While salaries are based on work experience and professional level, some hospitals
also pay a bonus to health workers according to their workload [21]. Given that HIV services
are free of charge and cannot directly generate profit for the hospitals, doctors and nurses that
work in HIV care often do not make as much money as their peers.While the hospital leaders
acknowledge the need for reform, they have little interest in supporting initiatives to increase
staff capacity or increase wages in the long term without additional financial support from the
government.
Another challenge for patients to successfully access HIV care in the current hospital care
setting is the high financial burden on HIV patients despite seemingly free HIV care. Across
the 18 hospitals investigated, the typical cost of a baseline physical examination before ART
treatment initiation ranged from 200-600RMB ($33–100 USD). While 90% of this is eligible
for reimbursement, the upfront cost represents a substantial barrier to access, particularly
among individuals with less economic resources or other competing needs. Only three counties
at the time of this research had implemented a fee exemption policy. Hospital and CDC admin-
istrators also expressed concerns about patients’ financial hardship. In some counties, patients
would also have to pay for medical fees incurred as a result of opportunistic infections.
There are a few limitations that should be noted in our calculations for testing completeness
and treatment proportions.We have limited our study hospitals to only county general hospi-
tals that had a minimum of 20 HIV+ patients during the study period.We also excluded pris-
oners, detainees and pregnant women from this study. Therefore, the results do not represent
the full spectrumof the HIV care cascade. Eight site investigators conducted our investigation
during different time periods. There may exist some degree of researcher subjectivity bias.
Additionally, while we stressed that the investigation was not to evaluate the performance of
each hospital, hospital staff may have misreported their current testing practices due to fear of
being held responsible.
Conclusions
In order for HIV-positive patients to fully benefit from ART, they need to know their HIV sta-
tus, be productively engaged in HIV care, start ART in a timely fashion and adhere to their
ART regimen on a long-term basis [5]. These represent the basic principles of the proposed
United Nations 90-90-90 Target [22], which was endorsed by China within the BRICS declara-
tion in late 2014 [23]. Our survey has shown that the current HIV testing practices and subse-
quent care procedures vary considerably across the county hospitals in Guangxi, which
reaffirms the need for a simpler, streamlined servicemodel to promote quicker, more efficient
flow of patients fromHIV screening to ART initiation. A critical paradigm shift needs to take
place in the mode of service delivery at the county-level, where HIV affected individuals be
able to gain access to the full spectrumof HIV care within one medical setting, and within an
abbreviated timeframe. This could be greatly facilitated by the adoption of a seek, test, treat
and retain model [24], which proposes universal ART treatment to all HIV infected individuals
regardless of symptoms or CD4 cell count level, as it is currently increasingly recommended in
some international guidelines [25,26]. These will be critical next steps if China is to optimally
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